Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,178 across all filing types
Latest filing 2024-03-15 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
U.S. FDA Inspection of the Company''s Aurangabad Facility.
Regulatory Filings Classification · 95% confidence The document is a short disclosure letter addressed to stock exchanges regarding a U.S. FDA inspection of the company's manufacturing facility. It mentions the issuance of a Form-483 with one observation and the company's commitment to address it. The document is brief (1986 characters) and serves as a regulatory disclosure pursuant to SEBI regulations. It does not contain financial data, audit results, or detailed report content. It is an announcement of a regulatory event rather than a full report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-15 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) disclosing the completion of a business transfer transaction involving the company and its subsidiary. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement about the completion of a transaction (business transfer agreement amendment and formalities) rather than a detailed financial report, audit, or management discussion. The document length is short (2157 characters) and it serves as a regulatory disclosure of a corporate event. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories like M&A filings or capital updates. It is not a full M&A filing or tender offer document, but a disclosure of a completed transaction.
2024-03-14 English
The Company executed an amendment agreement to the Business Transfer Agreement dated October 16, 2023, with Lupin Manufacturing Solutions Limited, wholly owned subsidiary of the Company, ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges disclosing the completion of a business transfer transaction involving the company and its subsidiary. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement about the completion of a transaction (business transfer agreement amendment and formalities completed). It does not contain financial statements, audit information, or detailed report data. The document is short (2156 characters) and serves as a regulatory disclosure of a corporate event rather than a full report or detailed financial filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2024-03-14 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the loss of share certificates and the request for stop transfer. It is addressed to stock exchanges and signed by the company secretary. The document is short (2853 characters) and is a regulatory compliance communication rather than a financial report or announcement of voting results, management changes, or capital changes. It does not contain financial data or results, nor is it a report or presentation. It fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance certificate.
2024-03-11 English
Intimation regarding loss of share certificate by the shareholder.
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the loss of share certificates and the request for stop transfer, addressed to stock exchanges. The document is short (2874 characters) and is a regulatory compliance communication rather than a financial report or announcement of voting results. It does not contain financial data, earnings, management changes, or meeting materials. It is a formal regulatory filing related to share certificate handling under SEBI regulations, fitting best under Regulatory Filings (RNS).
2024-03-11 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. It details the issuance of duplicate share certificates in lieu of lost share certificates. The document is addressed to stock exchanges and signed by the company secretary. It does not contain financial statements, earnings data, or management discussion. It is a regulatory compliance filing related to share certificate issuance and not a financial report or announcement of voting results. Therefore, it fits best under Regulatory Filings (RNS). The document length is short (2882 characters), and it is a formal compliance certificate, not a report or announcement of a report.
2024-03-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.